Skip to main content
. Author manuscript; available in PMC: 2019 Nov 29.
Published in final edited form as: Inflamm Bowel Dis. 2018 Nov 29;24(12):2565–2578. doi: 10.1093/ibd/izy242

TABLE 1:

Patient Demographics

Subject No. Sex Age, y Disease
Duration, y		 Extent of
Disease		 Clinical Score
(PUCAI or SCCAI)		 Concomitant Medications
BCH-157 Male 18   3.5 Pancolitis 40P 5-ASA, corticosteroid
BCH-877 Female 13   8.75 Left-sided 40P 5-ASA, 6-MP, corticosteroid
BCH-1057 Male 17   1.25 Left-sided 70P Antibiotic, 6-MP, corticosteroid
BCH-1077 Male 17   2 Left-sided 35P 5-ASA, corticosteroid
BCH-1120 Female 20   0 Pancolitis 40P Antibiotic
BCH-1192 Male 20   7 Pancolitis 20P Anti-TNF
BCH-1214 Female 19   2 Left-sided 0P 6-MP, anti-TNF
BWH-8855 Female 52   9.86 Left-sided 0S 5-ASA
BWH-8854 Male 56   9.86 Left-sided 1S 5-ASA
BWH-8874 Male 21   5.92 Left-sided 2S 5-ASA
BWH-8878 Female 29   0.95 Pancolitis 1S Anti-TNF
BWH-8879 Male 45   2.95 Left-sided 0S 5-ASA, 6-MP, anti-TNF
BWH-8881 Female 27   8.96 Left-sided 0S 5-ASA